{"transactions":[{"id":1893704,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":113518,"kind":"person","name":"Crawford Candace","position":1,"cik":"0001864097","reported_name":"Crawford Candace","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock options","published_at":"2023-05-15T16:30:33.000Z","date":"2023-04-24","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options are being issued in connection with serving on the board of directors of SBEV, pursuant to the 2020 Long-Term Incentive Compensation Plan. 10,417 options will vest on the 5th day of each month starting May 2023 until December 2023 and 10,416 options will vest on the 5th day of each month starting January 2024 until April 2024."}],"balance_after":125000,"derivative":{"exercise_price":1.12,"expiration_date":"2033-04-05","underlying":"Common stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001731122-23-000934","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864097/000173112223000934/ownership.xml","form_type":"4"}},{"id":2304977,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":113518,"kind":"person","name":"Crawford Candace","position":1,"cik":"0001864097","reported_name":"Crawford Candace","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2022-04-05T17:25:54.000Z","date":"2021-05-16","kind":"grant","acquired":true,"shares":333333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the Options vested immediately, one-third of the Options vested on May 15, 2021, and one-third of the Options vest on May 15, 2022."}],"balance_after":333333,"derivative":{"exercise_price":2.25,"expiration_date":"2026-05-15","underlying":"Common Stock","underlying_shares":333333},"source":{"system":"sec-edgar","filing":"0001731122-22-000676","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864097/000173112222000676/ownership.xml","form_type":"4"}},{"id":2313088,"issuer":{"id":8508,"kind":"organization","name":"Endovia Health Sciences, Inc."},"owners":[{"id":113518,"kind":"person","name":"Crawford Candace","position":1,"cik":"0001864097","reported_name":"Crawford Candace","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (Right to Buy)","published_at":"2022-03-31T21:44:44.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Two-thirds of the Options vested on September 30, 2021, and one-third of the Options vest on September 30, 2022."}],"balance_after":125000,"derivative":{"exercise_price":2.6,"expiration_date":"2026-09-30","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001731122-22-000657","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1864097/000173112222000657/ownership.xml","form_type":"4"}}]}